医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Molex Expands Global Medical Electronics Market Capabilities with Acquisition of Affinity Medical Technologies

2012年10月12日 AM06:00
このエントリーをはてなブックマークに追加


 

LISLE, Ill.

Molex Incorporated (NASDAQ: MOLX) (NASDAQ: MOLXA), global manufacturer of complete interconnect solutions, announced today it has acquired Affinity Medical Technologies LLC, based in Costa Mesa, Calif. Affinity Medical Technologies specializes in designing and manufacturing custom medical interconnect products. According to Tim Ruff, Molex Senior Vice President of Business Development and Corporate Strategy, this is a strategic acquisition that will help expand Molex’s presence in the global medical electronics market.

“Affinity Medical Technologies is a great fit for Molex because it expands our capabilities in key areas that will help us better serve the global medical electronics market,” Ruff said. “Its products are used in almost every area of medical monitoring. Affinity Medical is well known for its quality and service as well as its expertise in product design, engineering, assembly and testing. Affinity Medical will help us quickly deliver the innovative solutions the medical electronics market demands. It has an excellent group of talented, experienced people with strong relationships within the medical electronics market.”

Mary Phillipp, Affinity Medical founder and CEO, agreed that Molex’s global presence and manufacturing capabilities will give both companies the opportunity for faster growth.

“Our capabilities complement each other,” she said. “Together, we are confident we can become a major force in the rapidly expanding global medical electronics market.”

Affinity Medical Technologies was founded in 1997. It will operate as a subsidiary of Molex Incorporated and will be part of the company’s Cable Products Group within the Global Integrated Products Division.

B. Riley & Co., LLC acted as exclusive financial advisors to Affinity Medical Technologies. B. Riley & Co., LLC is a leading independent investment bank that provides a full array of corporate finance, research, and sales and trading services to institutional clients.

About Molex Incorporated

Providing more than connectors, Molex delivers complete interconnect solutions for a number of markets including data communications, telecommunications, consumer electronics, industrial, automotive, medical, military, lighting and solar. Established in 1938, the company operates 41 manufacturing locations in 16 countries.

Molex is a registered trademark of Molex Incorporated.

CONTACT

Molex Incorporated
Investor Contact:
Steve Martens,
630-527-4344
Vice President, Investor Relations
steve.martens@molex.com
or
Editorial
Contact:
Gregg Voss, 630-527-4262
Corporate Communications
Manager
gregg.voss@molex.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • サラダックス・バイオメディカル、サルバトーレ・J・サラモネ博士が権威ある C.E. Pippenger博士賞を受賞したと発表
  • Japan’s MHLW Approves PADCEV® (enfortumab vedotin) for Advanced Urothelial Cancer
  • VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan
  • TAE Life Sciences Announces Installation of First Accelerator-based Neutron Beam System for Biologically Targeted Radiation Therapy at Xiamen Humanity Hospital in China
  • New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically Ventilated Neonates